Next Science Share Price and Company Fundamentals



Price
$0.145
Change
0.000 (0.000%)
52 week range
0.056 - 0.155

Last traded: 12/31/2025

Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial wound Gel; acne gel; oral rinse; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

-

Beta

1.22

Market cap

$42.43M

Enterprise value

$46.69M

Company profile

Industry / Sector Drug Manufacturers - Specialty & Generic / Healthcare
Website https://www.nextscience.com
Mailing address Australia Square Level 14 264-278 George Street Sydney NSW 2000 Australia
Phone / Fax 61 4 1229 2977 /

Dividends

More: Next Science Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Next Science paid $- dividend and the ex-dividend date was 02 Feb 2026.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.NXS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Feb 2026, following are the company executives and directors listed on Next Science.

Name Title Age Total Pay
Dr. Matthew Franco Myntti Founder & CTO
Mr. Jon Swanson Chief Strategy Officer
Daniel Canon Vice President of Operations
Francoise Dixon Head of Investor Relations
Mr. Robert Bell Senior Vice President of North American Sales
Ms. Gillian Maria Nairn AGIA, B.A., L.L.B., L.L.M., MAICD Company Secretary

Profitability and management effectiveness

Profit margin

-42.74%

Operating margin

-41.23%

Return on assets

-50.99%

Return on equity

-289.70%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Next Science is 42.43M and its enterprise value is 46.69M. The enterprise value to revenue ratio of NXS is 2.12. The enterprise value to EBITDA ratio of NXS is -5.68.

The NXS's stocks Beta value is 1.22 making it 22% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Next Science (NXS)

Next Science (ASX:NXS) Frequently Asked Questions

1. What is Next Science's Stock Symbol?

Next Science trades on ASX under the ticker symbol "NXS".

2. What is Next Science's stock price today?

One share of NXS stock can currently be purchased for approximately $0.145.

3. How can I contact Next Science?

Next Science's mailing address is Australia Square Level 14 264-278 George Street Sydney NSW 2000 Australia. The company can be reached via phone at 61 4 1229 2977.

4. What is Next Science's official website?

The official website of Next Science is https://www.nextscience.com.